PLTP activity is a risk factor for subsequent cardiovascular events in CAD patients under statin therapy: the AtheroGene Study

PLTP activity is a risk factor for subsequent cardiovascular events in CAD patients under statin therapy: the AtheroGene Study

Phospholipid transferprotein (PLTP) mediates both net transfer and exchange of phospholipids between different lipoproteins. Although many studies have investigated the role of PLTP in atherogenesis, the role of PLTP in atherosclerotic diseases is unclear. We investigated the association of serum PL...

Full description

Bibliographic Details
Main Authors: Axel Schlitt, Stefan Blankenberg, Christoph Bickel, Karl J. Lackner, Gunnar H. Heine, Michael Buerke, Karl Werdan, Lars Maegdefessel, Uwe Raaz, Hans J. Rupprecht, Thomas Munzel, Xian-Cheng Jiang
Format: Article
Language:English
Published: Elsevier 2009-04-01
Series:Journal of Lipid Research
Subjects:
lipid transfer proteins
atherosclerosis
3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520308701

Internet

http://www.sciencedirect.com/science/article/pii/S0022227520308701

Similar Items